유전성 난청의 진단과 치료

키워드

참고문헌 (124)

1. Morton NE, "Genetic epidemiology of hearing impairment", Ann N Y Acad Sci, 630, pp.16~31 (1991)
2. "Deafness and hearing loss"[URL]
3. "Hereditary Hearing Loss Homepage"[URL]
4. Smith RJ, "Sensorineural hearing loss in children", Lancet, 365(9462), pp.879~890 (2005)
5. Sanger F, "A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase", J Mol Biol, 94(3), pp.441~448 (1975)
6. Rodriguez-Ballesteros M, "A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene(OTOF)in subjects with nonsyndromic hearing impairment and auditory neuropathy", Hum Mutat, 29(6), pp.823~831 (2008)
7. Jung J, "Novel COCH p. V123E mutation, causative of DFNA9 sensorineural hearing loss and vestibular disorder, shows impaired cochlin post-translational cleavage and secretion", Hum Mutat, 36(12), pp.1168~1175 (2015)
8. Vore AP, "Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness", Arch Otolaryngol Head Neck Surg, 131(12), pp.1057~1063 (2005)
9. Prezant TR, "Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness", Nat Genet, 4(3), pp.289~294 (1993)
10. Bitner-Glindzicz M, "Ototoxicity caused by aminoglycosides", BMJ, 335(7624), pp.784~785 (2007)
11. Kenneson A, "GJB2(connexin 26)variants and nonsyndromic sensorineural hearing loss : a HuGE review", Genet Med, 4(4), pp.258~274 (2002)
12. Na G, "Effect of cochlear implantation on hearing fluctuation in patients with biallelic SLC26A4 variants", Audiol Neurootol, 26(2), pp.111~120 (2021)
13. Rabbani B, "Next-generation sequencing : impact of exome sequencing in characterizing Mendelian disorders", J Hum Genet, 57(10), pp.621~632 (2012)
14. Sloan-Heggen CM, "Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss", Hum Genet, 135(4), pp.441~450 (2016)
15. Snowden AW, "Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo", Curr Biol, 12(24), pp.2159~2166 (2002)
16. Luo H, "Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL", Leuk Lymphoma, 58(2), pp.445~456 (2017)
17. Fire A, "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature, 391(6669), pp.806~811 (1998)
18. Nam GS, "The TECTA mutation R1890C is identified as one of the causes of genetic hearing loss : a case report", BMC Med Genet, 20(1), pp.57~ (2019)
19. Yan D, "Screening of deafness-causing DNA variants that are common in patients of European ancestry using a microarray-based approach", PLoS One, 12(3), pp.e0169219~ (2017)
20. Tsukada K, "Ethnic-specific spectrum of GJB2 and SLC26A4 mutations : their origin and a literature review", Ann Otol Rhinol Laryngol, 124(Suppl 1), pp.61S~76S (2015)
21. Dai P, "Concurrent hearing and genetic screening of 180, 469 neonates with follow-up in Beijing, China", Am J Hum Genet, 105(4), pp.803~812 (2019)
22. Yuan Y, "Comprehensive genetic testing of Chinese SNHL patients and variants interpretation using ACMG guidelines and ethnically matched normal controls", Eur J Hum Genet, 28(2), pp.231~243 (2020)
23. Shin JW, "Genetic screening of GJB2 and SLC26A4 in Korean cochlear implantees : experience of soree ear clinic", Clin Exp Otorhinolaryngol, 5(Suppl 1), pp.S10~13 (2012)
24. Jung J, "Genetic Predisposition to Sporadic Congenital Hearing Loss in a Pediatric Population", Sci Rep, 7, pp.45973~ (2017)
25. Bae JW, "Molecular and clinical characterization of the variable phenotype in Korean families with hearing loss associated with the mitochondrial A1555G mutation", PLoS One, 7(8), pp.e42463~ (2012)
26. Park HJ, "Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans", Clin Genet, 67(2), pp.160~165 (2005)
27. 김보경, "한국인에서의 SLC26A4 돌연변이", 대한이비인후-두경부외과학회지, 57(11), pp.733~737 (2014), 대한이비인후과학회[DOI]
28. Lee KY, "Molecular analysis of the GJB2, GJB6 and SLC26A4genes in Korean deafness patients", Int J Pediatr Otorhinolaryngol, 72(9), pp.1301~1309 (2008)
29. Shin JW, "Genetic screening of GJB2 and SLC26A4 in Korean cochlear implantees : experience of soree ear clinic", Clin Exp Otorhinolaryngol, 5 Suppl 1(Suppl 1), pp.S10~13 (2012)
30. 최수영, "Construction of a DNA Chip for Screening of Genetic Hearing Loss", Clinical and Experimental Otorhinolaryngology, 2(1), pp.44~47 (2009), 대한이비인후과학회
31. Sagong B, "A rapid method for simultaneous screening of multi-gene mutations associated with hearing loss in the Korean population", PLoS One, 8(3), pp.e57237~ (2013)
32. Han KH, "Establishment of a flexible real-time polymerase chain reaction-based platform for detecting prevalent deafness mutations associated with variable degree of sensorineural hearing loss in Koreans", PLoS One, 11(9), pp.e0161756~ (2016)
33. Lee SY, "Flexible real-time polymerase chain reaction-based platforms for detecting deafness mutations in Koreans: a proposed guideline for the etiologic diagnosis of auditory neuropathy spectrum disorder", Diagnostics (Basel), 10(9) (2020)
34. Mori K, "Social health insurance-based simultaneous screening for 154 mutations in 19 deafness genes efficiently identified causative mutations in Japanese hearing loss patients", PLoS One, 11(9), pp.e0162230~ (2016)
35. Rim JH, "Activation of KCNQ4as a therapeutic strategy to treat hearing loss", International Journal of Molecular Sciences, 22(5), pp.2510~ (2021)
36. Jung J, "Whole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss", Sci Rep, 8(1), pp.16659~ (2018)
37. Jinsei Jung, "Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment", Experimental and Molecular Medicine, 51, pp.1~12 (2019), 생화학분자생물학회[DOI]
38. Shin DH, "A recurrent mutation in KCNQ4 in Korean families with nonsyndromic hearing loss and rescue of the channel activity by KCNQ activators", Hum Mutat, 40(3), pp.335~346 (2019)
39. Askew C, "Adeno-associated virus gene replacement for recessive inner ear dysfunction : Progress and challenges", Hear Res, 394, pp.107947~ (2020)
40. Gilbert LA, "Genome-scale CRISPR-mediated control of gene repression and activation", Cell, 159(3), pp.647~661 (2014)
41. Thakore PI, "Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements", Nat Methods, 12(12), pp.1143~1149 (2015)
42. Qi LS, "Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression", Cell, 152(5), pp.1173~1183 (2013)
43. Shibata SB, "RNA interference prevents autosomal-dominant hearing loss", Am J Hum Genet, 98(6), pp.1101~1113 (2016)
44. Maeda Y, "In vitro and in vivo suppression of GJB2 expression by RNA interference", Hum Mol Genet, 14(12), pp.1641~1650 (2005)
45. "Neurosci Lett", 2015, 66~72
46. Lentz JJ, "Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness", Nat Med, 19(3), pp.345~350 (2013)
47. Zou B, "The application of genome editing in studying hearing loss", Hear Res, 327, pp.102~108 (2015)
48. Komor AC, "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", Nature, 533(7603), pp.420~424 (2016)
49. Jinek M, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science, 337(6096), pp.816~821 (2012)
50. Silva G, "Meganucleases and other tools for targeted genome engineering : perspectives and challenges for gene therapy", Curr Gene Ther, 11(1), pp.11~27 (2011)
51. Chen K, "TALENs : customizable molecular DNA scissors for genome engineering of plants", J Genet Genomics, 40(6), pp.271~279 (2013)
52. Klug A, "The discovery of zinc fingers and their applications in gene regulation and genome manipulation", Annu Rev Biochem, 79, pp.213~231 (2010)
53. Farooq R, "CRISPR", Cas9 : targeted genome editing for the treatment of hereditary hearing loss, 2020, pp.61(1), 51~65
54. Hirano S, "Structural basis for the altered PAM specificities of engineered CRISPR-Cas9", Mol Cell, 61(6), pp.886~894 (2016)
55. Kleinstiver BP, "Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition", Nat Biotechnol, 33(12), pp.1293~1298 (2015)
56. Anzalone AV, "Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors", Nat Biotechnol, 38(7), pp.824~844 (2020)
57. Bedrosian JC, "In vivo delivery of recombinant viruses to the fetal murine cochlea : transduction characteristics and longterm effects on auditory function", Mol Ther, 14(3), pp.328~335 (2006)
58. Han JJ, "Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector", Hum Gene Ther, 10(11), pp.1867~1873 (1999)
59. Pietola L, "HOX-GFP and WOX-GFP lentivirus vectors for inner ear gene transfer", Acta Otolaryngol, 128(6), pp.613~620 (2008)
60. Wei Y, "Effect of lentiviruses carrying enhanced green fluorescent protein injected into the scala media through a cochleostomy in rats", Am J Otolaryngol, 34(4), pp.301~307 (2013)
61. Shu Y, "Adenovirus vectors target several cell subtypes of mammalian inner ear in vivo", Neural Plast, 2016, pp.9409846~ (2016)
62. Alba R, "Gutless adenovirus : last-generation adenovirus for gene therapy", Gene Ther, 12(Suppl 1), pp.S18~27 (2005)
63. Husseman J, "Gene therapy in the inner ear using adenovirus vectors", Adv Otorhinolaryngol, 66, pp.37~51 (2009)
64. Venail F, "Coxsackie adenovirus receptor and alpha nu beta3", alpha nu beta5 integrins in adenovirus gene transfer of rat cochlea, 2007, pp.14(1), 30~37
65. Kesser BW, "An in vitro model system to study gene therapy in the human inner ear", Gene Ther, 14(15), pp.1121~1131 (2007)
66. Yang J, "Ectopic hair celllike cell induction by Math1 mainly involves direct transdifferentiation in neonatal mammalian cochlea", Neurosci Lett, 549, pp.7~11 (2013)
67. Takada Y, "Ototoxicity-induced loss of hearing and inner hair cells is attenuated by HSP70 gene transfer", Mol Ther Methods Clin Dev, 2, pp.15019~ (2015)
68. Yang J, "Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination", J Virol, 73(11), pp.9468~9477 (1999)
69. Mingozzi F, "Immune responses to AAV vectors : overcoming barriers to successful gene therapy", Blood, 122(1), pp.23~36 (2013)
70. Calcedo R, "Humoral immune response to AAV", Front Immunol, 4, pp.341~ (2013)
71. Zinn E, "In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector", Cell Rep, 12(6), pp.1056~1068 (2015)
72. Askew C, "Tmc gene therapy restores auditory function in deaf mice", Sci Transl Med, 7(295), pp.295~ (2015)[DOI]
73. Akil O, "Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy", Neuron, 75(2), pp.283~293 (2012)
74. Chien WW, "Gene therapy for sensorineural hearing loss", Ear Hear, 36(1), pp.1~7 (2015)
75. Jero J, "Cochlear gene delivery through an intact round window membrane in mouse", Hum Gene Ther, 12(5), pp.539~548 (2001)
76. Konishi M, "Gene transfer into guinea pig cochlea using adeno-associated virus vectors", J Gene Med, 10(6), pp.610~618 (2008)
77. Fine EJ, "Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes", Sci Rep, 5, pp.10777~ (2015)
78. Cao M, "Dual AAV", IL-10 plus STAT3 anti-inflammatory gene delivery lowers atherosclerosis in LDLR KO mice, but without increased benefit, 2012, pp.2012, 524235~
79. Topilina NI, "Recent advances in in vivo applications of intein-mediated protein splicing", Mob DNA, 5(1), pp.5~ (2014)
80. Li J, "Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy", Hum Gene Ther, 19(9), pp.958~964 (2008)
81. Truong DJ, "Development of an intein-mediated split-Cas9 system for gene therapy", Nucleic Acids Res, 43(13), pp.6450~6458 (2015)
82. Al-Moyed H, "A dual-AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock-out mice", EMBO Mol Med, 11(1) (2019)
83. Akil O, "Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model", Proc Natl Acad Sci U S A, 116(10), pp.4496~4501 (2019)
84. Landegger LD, "A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear", Nat Biotechnol, 35(3), pp.280~284 (2017)
85. Suzuki J, "Cochlear gene therapy with ancestral AAV in adult mice : complete transduction of inner hair cells without cochlear dysfunction", Sci Rep, 7, pp.45524~ (2017)
86. Isgrig K, "AAV2. 7m8 is a powerful viral vector for inner ear gene therapy", Nat Commun, 10(1), pp.427~ (2019)
87. Gyorgy B, "Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV", Mol Ther, 25(2), pp.379~391 (2017)
88. Bakhshandeh B, "A Comprehensive review on exosomes and microvesicles as epigenetic factors", Curr Stem Cell Res Ther, 12(1), pp.31~36 (2017)
89. Kooijmans SA, "Exosome mimetics : a novel class of drug delivery systems", Int J Nanomedicine, 7, pp.1525~1541 (2012)
90. Ren LL, "Math1 gene transfer based on the delivery system of quaternized chitosan", Na-carboxymethyl-beta-cyclodextrin nanoparticles, 2010, pp.10(11), 7262~7265
91. Zuris JA, "Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo", Nat Biotechnol, 33(1), pp.73~80 (2015)
92. Shcharbin DG, "Dendrimers in gene transfection", Biochemistry(Mosc), 74(10), pp.1070~1079 (2009)
93. Praetorius M, "Expression patterns of non-viral transfection with GFP in the organ of Corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors", HNO, 56(5), pp.524~529 (2008)
94. Zhou H, "Linear polyethylenimine-plasmid DNA nanoparticles are ototoxic to the cultured sensory epithelium of neonatal mice", Mol Med Rep, 11(6), pp.4381~4388 (2015)
95. Tamura T, "Drug delivery to the cochlea using PLGA nanoparticles", Laryngoscope, 115(11), pp.2000~2005 (2005)
96. Puligilla C, "Sox2induces neuronal formation in the developing mammalian cochlea", J Neurosci, 30(2), pp.714~722 (2010)
97. Pinyon JL, "Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear", Sci Transl Med, 6(233), pp.233ra54~ (2014)
98. Shibata SB, "Intravenous rAAV2", 9 injection for murine cochlear gene delivery, 2017, pp.7(1), 9609~
99. Yoshimura H, "Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation", Sci Rep, 8(1), pp.2980~ (2018)
100. Kawamoto K, "The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice", Mol Ther, 4(6), pp.575~585 (2001)
101. Wu X, "Gene therapy via canalostomy approach preserves auditory and vestibular functions in a mouse model of Jervell and Lange-Nielsen syndrome type 2", Nat Commun, 12(1), pp.697~ (2021)
102. Chien WW, "Cochlear gene transfer mediated by adeno-associated virus : comparison of two surgical approaches", Laryngoscope, 125(11), pp.2557~2564 (2015)
103. Kilpatrick LA, "Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear", Gene Ther, 18(6), pp.569~578 (2011)
104. Ruel J, "Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice", Am J Hum Genet, 83(2), pp.278~292 (2008)
105. Hilgert N, "Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7", 11, 2008, pp.74(3), 223~232
106. Pan B, "TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear", Neuron, 79(3), pp.504~515 (2013)
107. Gao X, "Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents", Nature, 553(7687), pp.217~221 (2018)
108. Ebrahim S, "Alternative splice forms influence functions of whirlin in mechanosensory hair cell stereocilia", Cell Rep, 15(5), pp.935~943 (2016)
109. Belyantseva IA, "Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia", Nat Cell Biol, 7(2), pp.148~156 (2005)
110. Chien WW, "Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice", Mol Ther, 24(1), pp.17~25 (2016)
111. Isgrig K, "Gene therapy restores balance and auditory functions in a mouse model of usher syndrome", Mol Ther, 25(3), pp.780~791 (2017)
112. Ouyang XM, "Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population", Hum Genet, 116(4), pp.292~299 (2005)
113. Yan J, "The structure of the harmonin", sans complex reveals an unexpected interaction mode of the two Usher syndrome proteins, 2010, pp.107(9), 4040~4045
114. Juliano RL, "The delivery of therapeutic oligonucleotides", Nucleic Acids Res, 44(14), pp.6518~6548 (2016)
115. Pan B, "Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c", Nat Biotechnol, 35(3), pp.264~272 (2017)
116. Adato A, "USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses", Eur J Hum Genet, 10(6), pp.339~350 (2002)
117. Gopal SR, "Zebrafish models for the mechanosensory hair cell dysfunction in Usher syndrome 3 reveal that clarin-1 is an essential hair bundle protein", J Neurosci, 35(28), pp.10188~10201 (2015)
118. Wangemann P, "Supporting sensory transduction : cochlear fluid homeostasis and the endocochlear potential", J Physiol, 576(Pt 1), pp.11~21 (2006)
119. Maeda Y, "Cochlear expression of a dominant-negative GJB2R75W construct delivered through the round window membrane in mice", Neurosci Res, 58(3), pp.250~254 (2007)
120. Yu Q, "Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice", Gene Ther, 21(1), pp.71~80 (2014)
121. Iizuka T, "Perinatal Gjb2 gene transfer rescues hearing in a mouse model of hereditary deafness", Hum Mol Genet, 24(13), pp.3651~3661 (2015)
122. Takada Y, "Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy", Hear Res, 309, pp.124~135 (2014)
123. "ClinicalTrials.gov"[URL]
124. Jacobson SG, "Gene therapy for leber congenital amaurosis caused by RPE65 mutations : safety and efficacy in 15 children and adults followed up to 3 years", Arch Ophthalmol, 130(1), pp.9~24 (2012)

관련 논문AI추천